Literature DB >> 26735600

Adjunctive Hyperbaric Oxygen Therapy or Alone Antibiotherapy? Methicillin Resistant Staphylococcus aureus Mediastinitis in a Rat Model.

Tolga Kurt1, Ahmet Vural2, Ahmet Temiz3, Ersan Ozbudak4, Ali Umit Yener1, Suzan Sacar5, Mustafa Sacar1.   

Abstract

OBJECTIVE: In the post-sternotomy mediastinitis patients, Staphylococcus aureus is the pathogenic microorganism encountered most often. In our study, we aimed to determine the efficacy of antibiotic treatment with vancomycin and tigecycline, alone or in combination with hyperbaric oxygen treatment, on bacterial elimination in experimental S. aureus mediastinitis.
METHODS: Forty-nine adult female Wistar rats were used. They were randomly divided into seven groups, as follows: non-contaminated, contaminated control, vancomycin, tigecycline, hyperbaric oxygen, hyperbaric oxygen + vancomycin and hyperbaric oxygen + tigecycline. The vancomycin rat group received 10 mg/kg/day of vancomycin twice a day through intramuscular injection. The tigecycline group rats received 7 mg/kg/day of tigecycline twice a day through intraperitoneal injection. The hyperbaric oxygen group underwent 90 min sessions of 100% oxygen at 2.5 atm pressure. Treatment continued for 7 days. Twelve hours after the end of treatment, tissue samples were obtained from the upper part of the sternum for bacterial count assessment.
RESULTS: When the quantitative bacterial counts of the untreated contaminated group were compared with those of the treated groups, a significant decrease was observed. However, comparing the antibiotic groups with the same antibiotic combined with hyperbaric oxygen, there was a significant reduction in microorganisms identified (P<0.05). Comparing hyperbaric oxygen used alone with the vancomycin and tigecycline groups, it was seen that the effect was not significant (P<0.05).
CONCLUSION: We believe that the combination of hyperbaric oxygen with antibiotics had a significant effect on mediastinitis resulting from methicillin-resistant Staphylococcus aureus. Methicillin-resistant Staphylococcus aureus mediastinitis can be treated without requiring a multidrug combination, thereby reducing the medication dose and concomitantly decreasing the side effects.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26735600      PMCID: PMC4690658          DOI: 10.5935/1678-9741.20150055

Source DB:  PubMed          Journal:  Braz J Cardiovasc Surg        ISSN: 0102-7638


  47 in total

1.  Efficacy of linezolid in the treatment of mediastinitis due to methicillin-resistant Staphylococcus aureus: an experimental study.

Authors:  Mustafa Sacar; Suzan Sacar; Ilknur Kaleli; Nural Cevahir; Zafer Teke; Semra Toprak Kavas; Ali Asan; Faruk Onder Aytekin; Ahmet Baltalarli; Huseyin Turgut
Journal:  Int J Infect Dis       Date:  2007-12-26       Impact factor: 3.623

2.  The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.

Authors:  E J Ellis-Grosse; T Babinchak; N Dartois; G Rose; E Loh
Journal:  Clin Infect Dis       Date:  2005-09-01       Impact factor: 9.079

3.  Postoperative mediastinitis in cardiovascular surgery postoperation. Analysis of 1038 consecutive surgeries.

Authors:  Michel Pompeu Barros de Oliveira Sá; Débora Oliveira Silva; Erika Nibbering de Souza Lima; Ricardo de Carvalho Lima; Frederico Pires Vasconcelos Silva; Fábio Gonçalves de Rueda; Rodrigo Renda de Escobar; Paulo Ernando Ferraz Cavalcanti
Journal:  Rev Bras Cir Cardiovasc       Date:  2010 Jan-Mar

4.  Dose-dependent hyperbaric oxygen stimulation of human fibroblast proliferation.

Authors:  K Brismar; F Lind; G Kratz
Journal:  Wound Repair Regen       Date:  1997 Apr-Jun       Impact factor: 3.617

5.  Comparative efficacy of tigecycline VERSUS vancomycin in an experimental model of soft tissue infection by methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin.

Authors:  Anastasia Antonopoulou; Thomas Tsaganos; Ira-Maria Tzepi; Helen Giamarellou; Evangelos J Giamarellos-Bourboulis
Journal:  J Chemother       Date:  2014-02-18       Impact factor: 1.714

6.  A compendium of strategies to prevent healthcare-associated infections in acute care hospitals.

Authors:  Deborah S Yokoe; Leonard A Mermel; Deverick J Anderson; Kathleen M Arias; Helen Burstin; David P Calfee; Susan E Coffin; Erik R Dubberke; Victoria Fraser; Dale N Gerding; Frances A Griffin; Peter Gross; Keith S Kaye; Michael Klompas; Evelyn Lo; Jonas Marschall; Lindsay Nicolle; David A Pegues; Trish M Perl; Kelly Podgorny; Sanjay Saint; Cassandra D Salgado; Robert A Weinstein; Robert Wise; David Classen
Journal:  Infect Control Hosp Epidemiol       Date:  2008-10       Impact factor: 3.254

7.  Methicillin-resistant Staphylococcus aureus infection epidemiology and clinical response from tigecycline soft tissue infection trials.

Authors:  Laura A Puzniak; Alvaro Quintana; Michele Wible; Tim Babinchak; Paul C McGovern
Journal:  Diagn Microbiol Infect Dis       Date:  2014-03-12       Impact factor: 2.803

8.  [The use of the vancomycin paste for sternal hemostasis and mediastinitis prophylaxis].

Authors:  Marcus Vinicius Ferraz de Arruda; Domingo Marcolino Braile; Marcos Rogério Joaquim; Fabio Augusto Suzuki; Raquel Helena Alves
Journal:  Rev Bras Cir Cardiovasc       Date:  2008 Jan-Mar

9.  Postoperative mediastinitis in cardiac surgery - microbiology and pathogenesis.

Authors:  B Gårdlund; C Y Bitkover; J Vaage
Journal:  Eur J Cardiothorac Surg       Date:  2002-05       Impact factor: 4.191

Review 10.  Recurrent Challenges for Clinicians: Emergence of Methicillin-Resistant Staphylococcus aureus, Vancomycin Resistance, and Current Treatment Options.

Authors:  Bansidhar Tarai; Poonam Das; Dilip Kumar
Journal:  J Lab Physicians       Date:  2013-07
View more
  2 in total

Review 1.  Hyperbaric oxygen influences chronic wound healing - a cellular level review.

Authors:  J Růžička; J Dejmek; L Bolek; J Beneš; J Kuncová
Journal:  Physiol Res       Date:  2021-12-31       Impact factor: 1.881

Review 2.  Regulation of Sterol Biosynthesis in the Human Fungal Pathogen Aspergillus fumigatus: Opportunities for Therapeutic Development.

Authors:  Sourabh Dhingra; Robert A Cramer
Journal:  Front Microbiol       Date:  2017-02-01       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.